Zantac (ranitidine) Voluntary Recall Information
Zantac (ranitidine) is a popular over-the-counter option for heartburn relief and the FDA recently issued a voluntary recall for some packages of ranitidine. These packages were found to have slightly higher levels of NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
What Patients Should Know
- Not all ranitidine medicines marketed in the U.S. are being recalled.
- The FDA is not recommending individuals stop taking all ranitidine medicines at this time.
- Consumers taking OTC ranitidine could consider using other OTC products approved for their condition.
- Patients taking prescription ranitidine who wish to discontinue use should talk to
their doctor about other treatment options.
GCSA recommends the following if you are stopping ranitidine:
If you are taking 150mg Ranitidine, change to famotidine 20mg
- If you are taking 300mg Ranitidine, change to famotidine 40mg